It looks as though the discussion on this is dying down, so at the risk of prolonging it a little, here is another lens to look at this through.
Before the sales disclosed in the announcement, DrC had 8.59m shares.
If we eventually get bought out for $30 (a tad conservative in the eyes of some perhaps), this would have yielded $258m.
However, having sold 300,000 shares, he would now be in line to receive $249m.
Now $9m is likely to be a huge amount for us on HC to contemplate missing out on - but in a couple of years receiving $249m instead of $258m probably wouldn't register too much (first world problems, I know).
- Forums
- ASX - By Stock
- RAC
- Ann: Appendix 3Y - Dr John Cullity
Ann: Appendix 3Y - Dr John Cullity, page-119
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.84 |
Change
0.080(4.56%) |
Mkt cap ! $312.7M |
Open | High | Low | Value | Volume |
$1.76 | $1.86 | $1.76 | $464.9K | 258.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | $1.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.86 | 4243 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | 1.835 |
1 | 25000 | 1.815 |
1 | 10000 | 1.800 |
1 | 8516 | 1.790 |
1 | 190 | 1.785 |
Price($) | Vol. | No. |
---|---|---|
1.860 | 4243 | 1 |
1.865 | 2690 | 1 |
1.880 | 866 | 1 |
1.890 | 6000 | 2 |
1.900 | 8590 | 3 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online